What is diagnostic testing?
The cancer care system is increasingly complex, marked by multiple hand-offs between primary care and specialty providers, inadequate communication among providers, and lack of clarity about a “medical home” (the ideal accountable care provider) for cancer patients. Three breast cancer survivors share how technology helped them and why Healthline’s new app is providing a much-needed platform for those living with the disease. Technology in Cancer Research & Treatment (TCRT) ( Impact Factor *) is a broad-spectrum, open access, peer-reviewed journal provides researchers an.
Last year, he announced the launch of the Precision Medicine Initiative — a bold new research effort to revolutionize how we improve health and treat disease. These two strategies together hold the promise of curing cancer or, at least, transforming it into a manageable chronic disease.
Negotiations and collaborations are launching now to decide which research trends and areas deserve the most support. Only disruptive innovations will be able to transform the status quo in cancer, leading patients to get more personalized and faster cancer care, while letting physicians do their job more effectively.
Prevention and diagnosis Cancer diagnosis must be early and accurate.
Many cancer types cannot be detected early enough at the moment, while others are detected in time, but treated too severely. This notion requires not only great healthcare facilities and new diagnosis technologies, but also the proactivity of patients.
Fluid biopsy During cancer treatments, re-biopsies are needed many times. It means a new sample from the ever-changing tumour must be obtained to define the next step of the therapy.
With the current, invasive biopsy techniques, this is a huge challenge not only for patients, but also for caregivers. Fluid biopsy extracts cancer cells from a simple blood sample. Real-time cancer diagnostics An intelligent surgical knife the iKnife was developed by Zoltan Takats of Imperial College London and works by using an old technology where an electrical current heats tissue to make incisions with minimal blood loss, but with iKnife the vaporized smoke is analyzed by a mass spectrometer to detect the chemicals in the biological sample.
This allows real-time identification of malignant tissue. Surgeons will love this surgical Jedi knife which can significantly reduce the length of operations in oncology.
This requires process innovation in healthcare, as well as more precise and specific cancer biomarkers supported by better screening technologies.
Treatment Today, we either use chemotherapy to destroy any reproducing cells causing serious side effects; or targeted therapies which show low rates of response due to heterogeneity of the tumour and the poor accuracy of matching treatments to patients.
The price of new drugs is going up steeply and personalized drugs cost even more, while effective cancer care be widely available to everyone. Next-generation targeted therapies In the case of AIDS, combining drugs with different targets resulted in the treatment that finally put a dent in the disease.
Research shows the same applies to cancer, but combining the increasing number of cancer therapies has so far proven difficult due to the sheer number of possible combinations. New approaches in the field of systems biology that use computer models to predict therapy effects are promising to cut through this complexity, and deliver effective combinational therapies in the coming years.
Over time, this will become the standard for assigning cancer treatment regimes. Artificial intelligence based therapy design Even if we can extract tumour cells from blood and sequence their DNA as fast as possible, making a decision about which treatment to choose next is still a struggle.
Artificial intelligence algorithms can. Multi-functional radiology Without doubt, the future belongs to interdisciplinary innovations. Similar innovations in treatment delivery would decrease side effects significantly while boosting treatment effectiveness.
In silico trials Current clinical trials take years and cost more than 2 billion dollars for every approved treatment. The number of failed drug candidates is enormous, so spending years and millions on a clinical trial is no guarantee it will lead to an approved treatment.
This is a huge risk for pharma companies. In silico trials using advanced biological networks, or the organs-on-a-chip technique would enable analysing on hundreds of thousands of drug candidates on billions of virtual human physiological models in seconds with supercomputers.
It would make drug discovery faster than ever. DNA cages Most cancer treatments today destroy not only cancerous cells, but also healthy ones.
The ultimate goal is delivering drugs only to cells that need to be treated. Using DNA cages holding a payload of drugs might be the answer. This method could be used in clinical trials soon. Cancer cells can trigger the DNA cage to open and thus the drug could only make an impact on those cells, but not the healthy ones.
Precision surgery Surgeons using surgical robots such as DaVinci are capable of performing operations with previously unachievable precision.Technology in Cancer Research & Treatment (TCRT) ( Impact Factor *) is a broad-spectrum, open access, peer-reviewed journal provides researchers an.
Advances in Breast Cancer Technology Breast cancer is something women face every day. Those two words can strike fear into the hearts of women. Years ago, women had home screening to check for lumps.
Over the years, there have been advances in the medical field on how to screen women for lumps.
This is because early detection has . The disadvantages of liquid biopsies can be overcome as the technology develops. BCRF investigators Daniel Haber, James Hicks, Peter Kuhn, and Michael Wigler have been leaders in the field of liquid biopsy.
The cancer care system is increasingly complex, marked by multiple hand-offs between primary care and specialty providers, inadequate communication among providers, and lack of clarity about a “medical home” (the ideal accountable care provider) for cancer patients.
Changing technology and methods of use. Older studies evaluated radiofrequency radiation exposure from analog cell phones. Today, cell phones use digital technology, which operates at a different frequency and a lower power level than analog phones.
The promise of curing cancer or, at least, transforming it into a manageable chronic disease. 14 Technologies That Will Shape The Future of Cancer Care.
The Medical Futurist 21 March A good example is Quell, a wearable technology with intensive nerve stimulation that is clinically proven to help manage chronic pain. Its use .